CMIC Group is Japan's largest CRO with over 25 years industry experiences supporting over 80% of new drug development in Japan. CMIC's Cranbury, NJ subsidiary provide pharmaceutical formulation development, analytical services, clinical and commercial manufacturing solutions for NDA and ANDA oral solid dosage products. CMIC's drug development services include:
- Controlled release and sustained release
- Dry blending - Fluid bed processes
- Wurster column bead drug layering and coating
- Tablet compression
- Aqueous film coating
Brands: Pharmaceutical Value Creator: as Japan's largest CRO supporting over 80% of new drug development in Japan, CMIC provides unique solutions from clinical CRO services, clinical and non-clinical testings, clinical site managements, contract development and manufacturing to contract sales solutions. We can help to support your growth into Japan market or Japanese companies to expand into US market. We are committed to continue innovation. Change ourselves. Change the future.